IL-10 reduces cytokine expression in non-muscle tissues, but its effect on skeletal muscle remains undefined. Therefore, we tested the hypothesis that endogenous IL-10 acts to reduce cytokines in the gastrocnemius muscle by comparing IL-6 and TNFα expression in wild-type (IL-10 +/+ ) and IL-10 deficient (IL-10 −/− ) mice following an inflammatory insult induced by peripheral LPS. IL-6 mRNA expression increased following LPS for both IL-10 +/+ and IL-10 −/− mice; the response was greater and prolonged in IL-10 −/− mice. Muscle TNFα mRNA also increased, but without differences between genotypes. IL-6 protein concentrations were elevated by LPS with a greater and prolonged response for IL-10 −/− mice, but TNFα did not change. These results provide the first in vivo evidence that endogenous IL-10 attenuates IL-6 expression by skeletal muscle in response to LPS.
Introduction
Emerging data have clearly demonstrated physiologically significant autocrine and paracrine roles of the pro-inflammatory cytokine IL-6 that is released from skeletal muscle (Frost and Lang, 2005; Pedersen and Febbraio, 2005) , such that it has been suggested to be a "myokine," a cytokine released from muscle cells (Keller et al., 2001; Steensberg et al., 2000) . Skeletal muscles also produce the pro-inflammatory cytokine TNFα (Frost et al., 2002; Phillips and Leeuwenburgh, 2005; Plomgaard et al., 2005) , and the majority of data suggest that TNFα is a key contributor to muscle protein loss following infection. Factors that regulate IL-6 and TNFα expression in skeletal muscle continue to be elucidated, and the importance of identifying these factors is crucial since skeletal muscle comprises the largest organ system in the body (40-50% of body mass). Thus, skeletal muscle can play a pivotal role in both local and systemic responses to an inflammatory insult. A potentially important regulator of IL-6 and TNFα expression and release is IL-10, the prototypical anti-inflammatory cytokine that has been shown to suppress the synthesis of pro-inflammatory cytokines by cells of the innate immune system (Moore et al., 2001) . It was recently reported that the expression of TNFα and IL-1β in response LPS is significantly greater in the plasma and livers of IL-10 −/− mice as compared to IL-10 +/+ mice (Zhong et al., 2006) . IL-6 and TNFα protein content are also increased in the brains of IL-10 −/− mice as compared to IL-10 +/+ controls (Agnello et al., 2000) . While these data support the idea that IL-10 is an important regulator of both IL-6 and TNFα in response to inflammatory stimuli, the potential role of IL-10 in regulating skeletal muscle-derived IL-6 or TNFα is unknown.
In response to LPS, skeletal muscle produces numerous cytokines including TNFα, IL-1β and IL-6 (Frost et al., 2002; Lang et al., 2003) which all have effects on muscle protein balance by affecting protein synthesis or degradation (Argiles
